Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide Extended-Release Tablets

budesonide · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Budesonide Extended-Release Tablets, covering 2025-09-16 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis [Phase 4]

See pricing